Endpoints News

Sanofi cans neuro disease trial		Read in browser

Thank you for reading, dupa dupackia!

basic

UPGRADE

M T Wed Th F

10 June, 2026

LGBTQ+ diversity drives innovation in biopharma — but transgender and non-binary professionals face rising challenges. Endpoints is going live with our fourth annual special report celebrating the honorees giving voice and visibility while forging ahead across life sciences. Join us.

presented by

Delivering excellence, close to home: Building the infrastructure for modern community oncology

SPOTLIGHT

Who pays the best (and worst) in biopharma? A look at typical employee salaries

Endpoints Women in Biopharma: Nominate for 2026

news

Parabilis' $670M IPO sets new biotech record, will fund cancer drug

Ethyreal lands $101M to treat both Graves' and thyroid eye disease

Sanofi to mull riliprubart’s future after stopping late-stage nerve disease study

The global one-stop conference convening experts across the drug discovery and development pipeline that will reshape the future of oncology therapeutics.

sponsored by American Association for Cancer Research

Research Assistant (Chemistry)

Arnatar

San Diego, CA, USA

Senior Director, Licensing Officer

Bayer

Cambridge, MA, USA

Recruit talent with Endpoints Careers

Contact Meg Estacio: mestacio@endpointsnews.com

in case you missed it

A father built a gene therapy for his daughter. He says an FDA request is the bottleneck

Eli Lilly's claims data deadline may kick off new 340B fight

Post-Hoc Live: How much is everyone in biopharma getting paid?

WuXi AppTec added to Pentagon's list of companies linked to Chinese military

GSK to acquire Nuvalent and its two cancer drugs under FDA review for $10.6B

Trodelvy misses again in lung cancer, but Gilead and Merck have an HIV success to soften the blow

News Briefing

Lilly offers up to $1B for Alzheimer's drug; Bial cuts failed Parkinson's drug

What a study at odds with Trump officials’ health guidance found on alcohol limits

Doctors should do more screening for excess body fat and its health risks

Every year Endpoints turns the spotlight on women leaders and innovators in the biotech and pharmaceutical space. We're seeking nominees for this year's list. Nicole DeFeudis explains what it's all about here, so please do get your sugges